1st Series on EOL (End of life) Care discussion – Think philosophy of life and death
date : 6/28/2013
Japan will experience an aging society by 2035 as one in three people in Japan will be over the age of 65. Japan will be the first country in human history to experience such a phenomenon, hence, it is Japan’s duty to ask questions; “How to Age and How to Die” and “The Ideal Ways of End of Life Care .” The aging issue has been known as a forbidden topic that cannot be discussed in the public but it is time to change. In the light of this, this consecutive seminar will aim to hold a discussion that allows young professionals from economic, medical, academic, media, legislative and administrative sectors to suggest action plans.
1st Series on EOL (End of life) Care discussion – Think philosophy of life and death
The discussion will investigate the issues surrounding end of life care to examine comprehensive points of view. This allows multispectral speakers to exchange their opinions in order to share the points at the issue with citizens.
Data: July 2nd (Tuesday) 19:00-21:00
Place: Tokyo 21c club (Shin-Marunouchi Build. 10F 1-5-1Marunouchi, Chiyoda-ku, Tokyo)
Organized by: Health and Global Policy Institution, NPO
Points of view: It allows multispectral speakers to exchange their opinions.
Targeted audience: Legislative body, Companies, Universities, Citizens, Mayor, Media (Reservation only)
Language: Japanese (No interpretation)
Program：
１. Discussion Point of EOL Care (Mr. Kazuhisa Takeuchi (McKinsey and Company ))
2. Philosophy of Life/Death and Community （Speaker：Yoshinori Hiroi (Professor at Chiba University, School of Law）
3. Interactive Discussion with Panelist (Seminar Proposers)
【Seminar Proposers】 （Syllabary order, Titles omitted）
– Mr. Daisuke Iwase President, Lifenet Insurance Company
– Mr. Kohei Onozaki Vice President, Corporate Affairs AstraZeneca K.K.
– Mr. Ken Shibusawa Board Chairman, Japan Center for International Exchange/ CEO of Commons Asset Management
– Mr. Kazuhisa Takeuchi McKinsey and Company
– Mr. Toshio Miyata Deputy Director of Office, Minister of Health, Labour and Welfare/ Surgeon
1st Series on EOL (End of life) Care discussion – Think philosophy of life and death
The discussion will investigate the issues surrounding end of life care to examine comprehensive points of view. This allows multispectral speakers to exchange their opinions in order to share the points at the issue with citizens.
Data: July 2nd (Tuesday) 19:00-21:00
Place: Tokyo 21c club (Shin-Marunouchi Build. 10F 1-5-1Marunouchi, Chiyoda-ku, Tokyo)
Organized by: Health and Global Policy Institution, NPO
Points of view: It allows multispectral speakers to exchange their opinions.
Targeted audience: Legislative body, Companies, Universities, Citizens, Mayor, Media (Reservation only)
Language: Japanese (No interpretation)
Program：
１. Discussion Point of EOL Care (Mr. Kazuhisa Takeuchi (McKinsey and Company ))
2. Philosophy of Life/Death and Community （Speaker：Yoshinori Hiroi (Professor at Chiba University, School of Law）
3. Interactive Discussion with Panelist (Seminar Proposers)
【Seminar Proposers】 （Syllabary order, Titles omitted）
– Mr. Daisuke Iwase President, Lifenet Insurance Company
– Mr. Kohei Onozaki Vice President, Corporate Affairs AstraZeneca K.K.
– Mr. Ken Shibusawa Board Chairman, Japan Center for International Exchange/ CEO of Commons Asset Management
– Mr. Kazuhisa Takeuchi McKinsey and Company
– Mr. Toshio Miyata Deputy Director of Office, Minister of Health, Labour and Welfare/ Surgeon
Exhibition date：2013-07-02
Top Research & Recommendations Posts
- [Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
- [Research Report] The Public Opinion Survey on Mental Health (August 12, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [Joint Report and Recommendations] “Rebalancing Health System: Innovation and Sustainability” A Joint Global Expert Meeting convened by the CSIS and HGPI
